New study to improve clinical decision making

James M. McKiernan, MD is an investigator in a new study to improve the clinical decision making in prostate cancer biopsy

James M. McKiernan, MD, Chairman of the Department of Urology at CUIMC, is an investigator in a new study of an non-invasive assessment tool to improve the clinical decision making in prostate cancer biopsy: Clinical utility of the exosome based ExoDx Prostate(IntelliScore) EPI test in men presenting for initial Biopsy with a PSA 2–10 ng/mL"


Read the full Springer Nature article